BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,083 | -19.2% | 399,544 | -2.0% | 0.04% | -18.2% |
| Q2 2023 | $18,662 | +10.3% | 407,558 | -2.2% | 0.04% | +4.8% |
| Q1 2023 | $16,926 | -21.8% | 416,731 | -1.5% | 0.04% | -26.3% |
| Q4 2022 | $21,658 | -99.9% | 422,871 | -2.5% | 0.06% | -13.6% |
| Q3 2022 | $23,359,000 | -16.1% | 433,631 | +0.1% | 0.07% | -9.6% |
| Q2 2022 | $27,844,000 | -28.6% | 433,175 | -9.0% | 0.07% | -9.9% |
| Q1 2022 | $38,981,000 | -6.4% | 476,157 | -2.2% | 0.08% | -5.8% |
| Q4 2021 | $41,668,000 | +4.4% | 486,622 | -1.3% | 0.09% | -7.5% |
| Q3 2021 | $39,914,000 | -1.3% | 493,047 | -1.9% | 0.09% | +1.1% |
| Q2 2021 | $40,443,000 | -5.4% | 502,595 | -1.4% | 0.09% | -11.5% |
| Q1 2021 | $42,743,000 | +0.9% | 509,837 | -3.6% | 0.10% | +30.0% |
| Q4 2020 | $42,358,000 | +0.2% | 528,984 | +0.6% | 0.08% | -13.0% |
| Q3 2020 | $42,294,000 | -7.9% | 525,681 | -1.8% | 0.09% | -12.4% |
| Q2 2020 | $45,918,000 | +5.5% | 535,500 | +0.5% | 0.10% | -10.3% |
| Q1 2020 | $43,526,000 | -2.2% | 532,785 | -0.7% | 0.12% | +20.6% |
| Q4 2019 | $44,494,000 | -31.2% | 536,619 | -27.3% | 0.10% | -36.6% |
| Q3 2019 | $64,626,000 | +9.5% | 738,088 | +2.3% | 0.15% | +13.3% |
| Q2 2019 | $58,997,000 | +142.9% | 721,523 | +86.6% | 0.14% | +95.7% |
| Q4 2018 | $24,285,000 | -21.7% | 386,667 | -3.9% | 0.07% | -6.8% |
| Q3 2018 | $31,035,000 | -5.5% | 402,217 | -9.6% | 0.07% | -3.9% |
| Q2 2018 | $32,851,000 | -46.9% | 444,859 | -53.2% | 0.08% | -48.7% |
| Q1 2018 | $61,868,000 | +7.5% | 949,962 | +6.5% | 0.15% | +11.1% |
| Q4 2017 | $57,532,000 | +12.5% | 892,099 | +8.5% | 0.14% | +6.3% |
| Q3 2017 | $51,159,000 | +0.0% | 822,070 | -2.9% | 0.13% | -7.3% |
| Q2 2017 | $51,156,000 | +72.6% | 846,324 | +47.9% | 0.14% | +71.2% |
| Q1 2017 | $29,635,000 | +17.4% | 572,203 | +0.9% | 0.08% | +12.7% |
| Q4 2016 | $25,247,000 | -54.2% | 567,318 | -51.1% | 0.07% | -11.2% |
| Q3 2016 | $55,098,000 | +107.4% | 1,158,978 | +96.8% | 0.08% | 0.0% |
| Q2 2016 | $26,564,000 | +28.9% | 588,870 | +17.3% | 0.08% | +6.7% |
| Q1 2016 | $20,602,000 | -19.3% | 502,039 | -25.0% | 0.08% | -23.5% |
| Q4 2015 | $25,541,000 | +16.7% | 669,154 | +0.3% | 0.10% | +14.0% |
| Q3 2015 | $21,880,000 | -63.8% | 667,009 | -23.0% | 0.09% | -58.9% |
| Q2 2015 | $60,504,000 | -17.9% | 866,538 | -19.7% | 0.21% | -17.1% |
| Q1 2015 | $73,729,000 | +22.2% | 1,078,837 | +31.0% | 0.25% | +26.6% |
| Q4 2014 | $60,347,000 | +13.0% | 823,482 | +10.8% | 0.20% | +11.2% |
| Q3 2014 | $53,381,000 | +5.2% | 743,132 | +5.6% | 0.18% | +7.8% |
| Q2 2014 | $50,758,000 | +9.7% | 703,927 | +11.5% | 0.17% | +1.8% |
| Q1 2014 | $46,262,000 | +22.7% | 631,423 | +16.8% | 0.16% | +21.6% |
| Q4 2013 | $37,707,000 | +44.1% | 540,382 | +35.4% | 0.13% | +30.1% |
| Q3 2013 | $26,163,000 | +17112.5% | 399,112 | +18033.2% | 0.10% | +10200.0% |
| Q2 2013 | $152,000 | – | 2,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |